Federal Project Grant Award Summary

The University of Virginia received a $1.7M project grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) to conduct research on preserving lung integrity and harnessing inflammation to treat burn-induced inhalation injury. The three-year award, which commenced May 1, 2026, and concludes April 30, 2029, supports hypothesis-driven biomedical research designed to develop innovative medical solutions for military service members and the broader public. This research initiative aligns with the DHA's focus on translational research and therapeutic development addressing critical health challenges relevant to military medicine.

The project will be conducted at the University of Virginia's Charlottesville, Virginia facility and is expected to deliver research findings, biomarker discoveries, and potentially therapeutic insights applicable to burn trauma care. As a major federal research institution with extensive experience in clinical research and biomedical investigation, the University of Virginia will leverage its established capabilities to advance understanding of inhalation injury pathophysiology and develop treatment strategies. The award represents one of the Military Medical Research and Development program's typical project grants, which generally range from $100,000 to $20M depending on scope and are competitively reviewed through a two-tier process emphasizing both technical merit and military relevance.